Aggressive care near patients’ end-of-life (EOL) entails limited therapeutic values, high costs, and compromised quality of life (QoL). In this study, we aimed to estimate the global prevalence of aggressive care in patients with cancer and explore potential subgroup differences. We searched PubMed, Embase, and the Cochrane Library from database inception to Feb 16, 2024. Eligible studies reported the prevalence of aggressive EOL care using at least one quantifiable measure. Random-effects models were used to derive the pooled prevalence and subgroup analyses were performed to investigate differences in the prevalence of aggressive care across regions, the country's level of economic development, tumor types, ages, and sample sizes. This review is registered with PROSPERO, number CRD42023467839. A total of 129 studies were included in this systematic review, of which 118 (91.5%) were from high-income countries. Studies were mostly conducted in the Americas (60, 46.5%), Europe (34, 26.4%), and Western Pacific (31, 24.0%). Measures of aggressive care were inconsistent across studies, with the most commonly used measure being the use of chemotherapy in the last 14 days of life (DOLs) (n = 87, 67.4%) and intensive care unit (ICU) stay in the last 30 DOLs (n = 87, 67.4%). The prevalence of the five claims-based measures of aggressive care, i.e., chemotherapy in the last 14 DOLs, ICU stay in the last 30 DOLs, repeated hospital admission in the last 30 DOLs, repeated emergency room (ER) visit in the last 30 DOLs, and hospice care <3 days before death were 11.6% (95% CI, 9.8%–13.4%), 14.4% (95% CI, 11.8%–17.0%), 17.9% (95% CI, 14.4%–21.4%), 14.8% (95% CI, 12.0%–17.6%), and 14.4% (95% CI, 11.2%–17.6%), respectively. Regional differences were statistically significant in the prevalence of ICU stay and repeated hospital admission in the last 30 DOLs (p < 0.01; p = 0.03). Patients with hematologic malignancies were more likely to receive aggressive care than those with solid tumors, as seen in their higher rates of chemotherapy in the last 14 DOLs (21.7% versus 11.6%; p = 0.03), ICU stay in the last 30 DOLs (25.5% versus 10.8%; p < 0.01), and hospice care <3 days before death (26.7% versus 14.2%; p < 0.01). In addition, the prevalence of chemotherapy in the last 14 DOLs (26.2%; p < 0.01) and repeated hospital admission in the last 30 DOLs (31.4%; p < 0.01) were highest among pediatric patients with cancer. This meta-analysis found that aggressive EOL care was common in patients with cancer, regardless of the definition used, and varied by regions and populations. It is necessary to be aware of the global burden of aggressive care for patients with cancer near their EOL and take prompt action to address it. 10.13039/501100001809 National Natural Science Foundation of China (Grant No. 72274004).

Antimicrobial resistance (AMR) represents a critical global health threat, with inappropriate antibiotic self-medication (ASM) being a key contributor. China—as the world’s largest antibiotic consumer—faces significant challenges despite regulatory efforts, compounded by limited contemporary data during the COVID-19 pandemic. A nationwide cross-sectional study was conducted using the 2021 China Family Health Index Survey (n = 11,031 participants across 120 cities). Trained investigators administered face-to-face questionnaires assessing ASM practices, decision-making factors, and sociodemographic characteristics. Multivariate logistic regression identified determinants of ASM. Overall, ASM prevalence was 33.7% (n = 3717), with no urban-rural difference (p > 0.05). Physician advice (78.2%), drug safety (67.1%), and efficacy (64.2%) were primary selection criteria; rural residents prioritized drug price and salesperson recommendations more than their urban counterparts (p < 0.01). Key predictors included higher ASM odds among females (OR = 1.30, 95%CI:1.18–1.43), middle-aged adults (46–59 years; OR = 1.20, 95%CI:1.02–1.42), those with health insurance (resident: OR = 1.33; commercial: OR = 1.62), and individuals with drinking histories (OR = 1.20, 95%CI:1.10–1.31). Lower odds were associated with primary education (OR = 0.69, 95%CI:0.58–0.81), unemployment (OR = 0.88, 95%CI:0.79–0.98), and absence of chronic diseases (OR = 0.56, 95%CI:0.47–0.67). One-third of Chinese residents engaged in ASM during the pandemic, driven by intersecting demographic and behavioral factors. Despite converging urban-rural prevalence rates, distinct decision-making drivers necessitate context-specific interventions, including strengthened pharmacy regulation in rural areas, tailored education programs for high-risk groups, and insurance system reforms to disincentivize self-medication.

Background: Quantitative flow ratio (QFR) is a novel technology to assess the functional significance of coronary stenoses based on standard coronary angiography, which can be alternatives to invasive fractional flow reserve (FFR) assessment. However, the evidence is limited to single-center studies and small sample sizes. This study systematically determined the diagnostic performance of QFR to diagnose functionally significant stenosis with FFR as the reference standard. Methods: A systematic review and meta-analysis of studies assessing the diagnostic performance of angiography-derived QFR systems were performed. All relevant studies from six literature databases were searched and screened according to the inclusion and exclusion criteria. The pooled sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR−), and diagnostic odds ratio (DOR), along with their 95% confidence intervals (CIs), were calculated using DerSimonian–Laird methodology. The summary receiver operating characteristic (SROC) curve and area under the curve were estimated. Meta-regression analysis was performed to identify a potential source of heterogeneity. Results: Fifty-seven studies comprising 13,215 patients and 16,125 vessels were included in the final analysis. At the vessel level, the pooled sensitivity and specificity of QFR for detecting a significant coronary stenosis were 0.826 (95% CI: 0.798–0.851) and 0.919 (95% CI: 0.902–0.933). Pooled LR+ and LR− were 10.198 (95% CI: 8.469–12.281) and 0.189 (95% CI: 0.163–0.219), with a pooled DOR of 53.968 (95% CI: 42.888–67.910). The SROC revealed an area under the curve (AUC) of 0.94 (95% CI: 0.91–0.96). The summary AUCs were 0.90 (95% CI: 0.87–0.92) for fixed-flow QFR (fQFR), 0.95 (95% CI: 0.92–0.96) for contrast-flow QFR (cQFR), 0.97 (95% CI: 0.95–0.98) for Murray law-based QFR (μQFR), and 0.91 (95% CI: 0.89–0.94) for non-specified QFR. The adjusted pooled DORs were as follows: 126.25 for μQFR, 45.49 for cQFR, 26.12 for adenosine-flow QFR (aQFR), 25.88 for fQFR, and 36.54 for non-specified QFR. Conclusions: The accuracy of angiography-derived QFR was strong to assess the functional significance of coronary stenoses with FFR as a reference. μQFR demonstrated the highest diagnostic performance among the five evaluated modes.

Antimicrobial resistance (AMR) represents a critical global health threat, with inappropriate antibiotic self-medication (ASM) being a key contributor. China—as the world's largest antibiotic consumer—faces significant challenges despite regulatory efforts, compounded by limited contemporary data during the COVID-19 pandemic. A nationwide cross-sectional study was conducted using the 2021 China Family Health Index Survey (n=11,031 participants across 120 cities). Trained investigators administered face-to-face questionnaires assessing ASM practices, decision-making factors, and sociodemographic characteristics. Multivariate logistic regression identified determinants of ASM. Overall ASM prevalence was 33.7% (n=3,717), with no urban-rural difference (p>0.05). Physician advice (78.2%), drug safety (67.1%), and efficacy (64.2%) were primary selection criteria; rural residents prioritized drug price and salesperson recommendations more than urban counterparts (p< 0.01). Key predictors included higher ASM odds among females (OR=1.30, 95%CI:1.18-1.43), middle-aged adults (46-59 years; OR=1.20, 95%CI:1.02-1.42), those with health insurance (resident: OR=1.33; commercial: OR=1.62), and individuals with drinking histories (OR=1.20, 95%CI:1.10-1.31). Lower odds were associated with primary education (OR=0.69, 95%CI:0.58-0.81), unemployment (OR=0.88, 95%CI:0.79-0.98), and absence of chronic diseases (OR=0.56, 95%CI:0.47-0.67). One-third of Chinese residents engaged in ASM during the pandemic, driven by intersecting demographic and behavioral factors. Despite converging urban-rural prevalence rates, distinct decision-making drivers necessitate context-specific interventions, including strengthened pharmacy regulation in rural areas, tailored education programs for high-risk groups, and insurance system reforms to disincentivize self-medication.